Eagle Pharmaceuticals, Inc. Stock price
Is Eagle Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Eagle Pharmaceuticals, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a Eagle Pharmaceuticals, Inc. forecast:
Analyst Opinions
7 Analysts have issued a Eagle Pharmaceuticals, Inc. forecast:
Don't miss a Thing! We will send you all news about Eagle Pharmaceuticals, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Eagle Pharmaceuticals, Inc. Stock News
Company Profile
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
| Head office | United States |
| CEO | Michael Graves |
| Employees | 134 |
| Founded | 2007 |
| Website | www.eagleus.com |


